Editorial: Otologic Trauma, Pathology, and Therapy
Front Cell Neurosci
.
2022 Apr 13:16:900074.
doi: 10.3389/fncel.2022.900074.
eCollection 2022.
Authors
Lukas D Landegger
1
,
Takeshi Fujita
2
,
Taha A Jan
3
,
Isabel Varela-Nieto
4
5
6
Affiliations
1
Department of Otolaryngology-Head and Neck Surgery, Vienna General Hospital, Medical University of Vienna, Vienna, Austria.
2
Department of Otolaryngology-Head and Neck Surgery, Kobe University Graduate School of Medicine, Kobe, Japan.
3
Department of Otolaryngology-Head and Neck Surgery, University of California, San Francisco, San Francisco, CA, United States.
4
Institute for Biomedical Research "Alberto Sols", Spanish National Research Council-Autonomous University of Madrid, Madrid, Spain.
5
Rare Diseases Networking Biomedical Research Centre, CIBER, Carlos III Institute of Health, Madrid, Spain.
6
La Paz Hospital Institute for Health Research, Madrid, Spain.
PMID:
35496907
PMCID:
PMC9043112
DOI:
10.3389/fncel.2022.900074
No abstract available
Keywords:
cisplatin; cochlea; genetics; hearing loss; otology; regeneration; synaptopathy.
Publication types
Editorial